Allergan posted a 12.9 percent sales increase to $1,528.4 million...
Allergan posted a 12.9 percent sales increase to $1,528.4 million for the quarter ended Sept. 30, driven by both its pharmaceutical and medical device businesses. On a constant currency basis, the increase in total product net sales was of 14.0 percent compared with the third quarter of 2012. Total specialty ...
To continue reading this article register now.
Already an Eyewear Intelligence subscriber? Sign in here.
Become a member today for full access from just €7,29 a week!
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.